N/A
N=66
BabySTEPs: Supportive Texts to Empower Parents
Alcohol Drinking
Bottom Line
View on ClinicalTrials.gov: NCT04719390 ↗Enrolled (actual)
66
Serious AEs
0.0%
Results posted
Jan 2025
Primary outcome: Primary: MRT Feasibility — 77.05 percentage of surveys completed
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Text Message (Behavioral)
- Age
- Adult · 18+ yrs
- Sex
- Female
- Sponsor
- The National Center on Addiction and Substance Abuse at Columbia University
- Primary completion
- Jun 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY MRT Feasibility |
77.05 | — |
| PRIMARY MRT Acceptability |
2.31 | — |
| PRIMARY Alcohol Use |
16; 58; 31; 27 | — |
| SECONDARY Maternal Self Efficacy |
6.54; 6.57; 6.54; 6.61 | — |
| SECONDARY Drinking Self-Efficacy |
6.26; 6.37; 6.35; 6.39 | — |
| SECONDARY Motivation |
6.13; 6.21; 6.21; 6.20 | — |
| SECONDARY Urge to Drink |
1.94; 1.92; 1.96; 1.88 | — |
Summary
This study is a pilot micro-randomized trial (MRT) that aims to establish feasibility, acceptability, and preliminary proof-of-concept of a text messaging intervention for postpartum alcohol use.
Eligibility Criteria
Inclusion Criteria
- adult women ages 18-45 years who gave birth to an infant that will remain in their care
- English-speaking
- own a text-enabled cell phone
- report a score of 2 or higher on the T-ACE alcohol risk screener AND (a) drinking weekly or more often in the past month OR (b) having 4 or more standard drinks at least monthly in the 12 months prior to becoming pregnant.
Exclusion Criteria
- women age 46 years or older
- women who did not recently give birth to an infant
- women who gave birth to an infant but that infant is not in their care
- individuals who do not speak English
- women who report a score of less than 2 on the T-ACE alcohol risk screener
- women who do not report either weekly or more drinking in the past month OR having 4 or more standard drinks at least monthly in the 12 months prior to becoming pregnant.
Data sourced from ClinicalTrials.gov (NCT04719390). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.